Merz Aesthetics

Find a healthcare professional

Find a healthcare professional

Learn more about the benefits of XEOMIN COSMETIC^®

Just like any medical decision, consult with your Healthcare Professional to determine if XEOMIN COSMETIC^® is right for you.

Questions to ask your doctor or dermatologist:

What is XEOMIN COSMETIC^®?
How does XEOMIN COSMETIC^® work?
What makes XEOMIN COSMETIC^® the newest generation of product?
Am I a good candidate for XEOMIN COSMETIC^®?
What can I expect after treatment with XEOMIN COSMETIC^®?
Is there anything else I should know about XEOMIN COSMETIC^®?

Actual patient and model. Individual results may vary.

Getting Started

Already a patient?

To access more information about XEOMIN COSMETIC^®, please enter the DIN (Drug Identification Number) or password provided to you by your Healthcare Professional. In this area, you’ll find more information on XEOMIN COSMETIC^®, videos, before and after photos, and frequently asked questions and answers.

Doctors performing Ultherapy

A doctor’s story: “Ultherapy makes it possible to obtain the natural results that make my patients happy.”

Live better. Feel better. Look better.

Less is More

Less is More: how to make the most of mid-life skin

Live better. Feel better. Look better.

The Gentle, Non-Invasive Alternative to Plastic Surgery

Ultherapy: The Gentle, Non-Invasive Alternative to Plastic Surgery

Live better. Feel better. Look better.

Safety Information

REFERENCES:
1. Kerscher M, et al. IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A. J Drugs Dermatol. 2019; 18(1): 52-7.
2. Frevert J. Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and XEOMIN®/Bocouture®. Drugs R D. 2010;10(2):1-7,67-73.
3. Torres S, et al. Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports. Clin Cosmet Investig Dermatol. 2014;7:11-7.
4. Stengel G, Bee EK. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines. Clin Interv Aging. 2011;6:281-4.
5. Prager W. Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines. Clin Pharmacol. 2013;5:39-52.

Copyright^© 2023 Merz Pharma Canada Ltd. All rights reserved. ULTHERAPY®, NEOCUTIS®, RADIESSE®, XEOMIN COSMETIC® and BELOTERO® are registered trademarks of their respective owners.